Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-07-03 16:23 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,288 vol |
223,549 | |
Filed 2020-06-19 10:31 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,124
+300 vol $7.08 each |
5,815 | |
Filed 2020-03-16 11:48 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,379
+394 vol $6.04 each |
5,515 | |
Filed 2019-12-18 11:22 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,034
+267 vol $7.62 each |
5,121 | |
Filed 2019-09-18 11:03 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,439
+701 vol $7.76 each |
4,854 | |
Filed 2019-08-16 15:59 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$349,168
+45,054 vol $7.75 each |
139,261 | |
Filed 2019-08-16 15:39 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,153 | ||
Filed 2019-08-12 16:06 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-13 15:57 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
94,207 | ||
Filed 2019-08-12 16:17 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-12 16:17 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
94,207 | ||
Filed 2019-08-12 16:06 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,430 |